Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 8/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 8/20 | 0.61 |
| ▸ | HTT | P42858 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 7/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | SMO | Q99835 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20109380 | 0.87 | KMT2A (0.62) | KMT2ANPSR1HTTMEN1MAPK1 | |
| SCHEMBL21239325 | 0.83 | KMT2A (0.58) | KMT2ANPSR1HTTMEN1MAPK1 | |
| SCHEMBL20109613 | 0.82 | SMO (0.57) | KMT2ANPSR1HTTMEN1MAPK1 | |
| SCHEMBL20108763 | 0.80 | KMT2A (1.00) | KMT2ANPSR1HTTMEN1MAPK1 | |
| SCHEMBL20109511 | 0.80 | KMT2A (0.63) | KMT2ANPSR1HTTMEN1MAPK1 | |
| SCHEMBL2023384 | 0.80 | KMT2A (0.74) | KMT2ANPSR1HTTMEN1MAPK1 | |
| SCHEMBL20108811 | 0.79 | KMT2A (0.41) | KMT2ANPSR1HTTMEN1MAPK1 | |
| SCHEMBL20109305 | 0.78 | KMT2A (0.60) | KMT2ANPSR1HTTMEN1MAPK1 | |
| SCHEMBL20109685 | 0.78 | KMT2A (0.60) | KMT2ANPSR1HTTMEN1MAPK1 | |
| SCHEMBL21221773 | 0.78 | KMT2A (0.71) | KMT2ANPSR1HTTMEN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190241574-A1 | PHENYL PHTHALAZINE DERIVATIVE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | SEOUL NATIONAL UNIVERSITY HOSPITAL (KR) | 2019-08-08 | — | — | US | claimed |
| WO-2018080216-A1 | PHENYL PHTHALAZINE DERIVATIVE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2018-05-03 | — | — | WO | claimed |
| US-10947241-B2 | Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same | SEOUL NATIONAL UNIVERSITY HOSPITAL (KR) | 2021-03-16 | — | — | US | disclosed |
| US-10947241-B2 | Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same | SEOUL NATIONAL UNIVERSITY HOSPITAL (KR) | 2021-03-16 | — | — | US | disclosed |
| US-20190241574-A1 | PHENYL PHTHALAZINE DERIVATIVE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | SEOUL NATIONAL UNIVERSITY HOSPITAL (KR) | 2019-08-08 | — | — | US | disclosed |
| US-20190241574-A1 | PHENYL PHTHALAZINE DERIVATIVE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | SEOUL NATIONAL UNIVERSITY HOSPITAL (KR) | 2019-08-08 | — | — | US | disclosed |
| WO-2018080216-A1 | PHENYL PHTHALAZINE DERIVATIVE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2018-05-03 | — | — | WO | disclosed |
| WO-2018080216-A1 | PHENYL PHTHALAZINE DERIVATIVE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2018-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190241574-A1 | PHENYL PHTHALAZINE DERIVATIVE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | PAH, HDAC5, SLC5A1 | KMT2A 804/4885NPSR1 1730/4885HTT 162/4885 |
| US-10947241-B2 | Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same | PAH, HDAC5, SLC5A1 | KMT2A 804/4885NPSR1 1730/4885HTT 162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.